VANI vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 30, 2026

VANI

51.1
AI Score
VS
VANI Wins

CBIO

48.5
AI Score

Investment Advisor Scores

VANI

51score
Recommendation
HOLD

CBIO

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric VANI CBIO Winner
Revenue 1,053 1.04M CBIO
Net Income -5.82M -23.28M VANI
Net Margin -552326.7% -2240.9% CBIO
Operating Income -5.82M -24.73M VANI
ROE -36.5% -12.7% CBIO
ROA -25781.3% -11.7% CBIO
Total Assets 22,559 199.13M CBIO
Cash 459 189.16M CBIO
Current Ratio 3.18 13.78 CBIO

Relative Price Performance (Last 90 Days)

VANI 1M: +5.6% · 3M: -2.2% CBIO 1M: -13.0% · 3M: -17.7%

Current Technical Phase

VANI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.9% over 20 days), RSI 51

RSI (14): 51.1 · Price: $1.33

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.2%), weak momentum, RSI 41

RSI (14): 41.2 · Price: $14.87

Fundamentals Snapshot

Metric VANI CBIO
Market Cap
Forward P/E -3.0 -5.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 1.0%
Operating Margin 0.0% -14.3%
EPS -0.40 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, VANI is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.